Cierra N. Sharp

Cierra N. Sharp

May 23, 2016

Group 6 Copy 46
0
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Where are the Pacific harbor seals in Mexico?

    Pacific Harbor seals use land to give birth to pups and molt, but once they return to the ocean to forage many...

    Why do wolverines need snow?

    A warming climate in the Arctic is having profound impacts on species that rely on snow and ice, like the polar...

    Backer Badge Funded